Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Arterolane (RBx 11160) dose-ranging in uncomplicated malaria
NCT00362050Phase 2Completed
- Sponsor
- Medicines for Malaria Venture
- Start
- Jun 2006
- Modality
- Light/Condition-Responsive Prodrugs
- Countries
- 3
01
Overview
A Phase 2 trial of Arterolane in Plasmodium falciparum malaria, sponsored by Medicines for Malaria Venture. Started Jun 2006; status: completed.
02
Drugs
Arterolane
03
Conditions
Plasmodium falciparum malaria
Beyond the preview
Go deeper on NCT00362050.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00362050.